The Doctor Youn Show cover image

Microdosing, Big Pharma, and Weight Loss: Inside GLP-1 Agonists Ozempic, Wegovy, Zepbound and Others with Dr. Tyna Moore

The Doctor Youn Show

00:00

Exploring GLP-1 Agonists and Metabolic Health

This chapter examines GLP-1 agonists like Ozempic and Wegovy, focusing on their weight loss potential and impact on metabolic health. It discusses the importance of addressing metabolic dysfunction and the need for lifestyle changes in conjunction with these medications. The conversation emphasizes the distinctions between natural peptides and traditional pharmaceuticals, advocating for a balanced approach in their implementation within naturopathic practices.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app